文献速递类风湿关节炎脊柱关节炎

类风湿关节炎与银屑病关节炎:疾病影响是否不同?一项在诊断时及治疗1年后的大型匹配研究

Rheumatoid arthritis and psoriatic arthritis: is the disease impact different? A large matching study at diagnosis and after 1 year of treatment.
PubMed 文献 · RMD Open · 2025-03-12

该研究在诊断时和治疗1年后比较了匹配的类风湿关节炎(RA)与银屑病关节炎(PsA)患者的疾病影响。PsA-DEPAR患者在诊断时SF-36心理健康评分较RA-tREACH患者差5.04单位(95%CI 2.21至7.87),治疗1年后差异仍存在(3.88,95%CI 1.90至5.86)。PsA-EAC患者治疗1年后活动受限较RA-EAC患者更重(-0.30,95%CI -0.50至-0.10)。其他患者报告结局领域无显著差异。

要点

  • PsA-DEPAR患者诊断时SF-36心理健康较RA-tREACH患者差5.04单位(95%CI 2.21至7.87),治疗1年后差异仍存在(3.88,95%CI 1.90至5.86)。
  • PsA-EAC患者治疗1年后活动受限较RA-EAC患者更重(-0.30,95%CI -0.50至-0.10)。
  • 其他患者报告结局领域在匹配的RA与PsA患者间无显著差异。

核心结论

  • 早期RA患者的疾病影响在大多数患者报告结局领域与匹配的早期PsA患者相似,但心理健康和功能受限在PsA治疗1年后更差。

研究设计与样本

  • 研究纳入tREACH试验的RA患者、DEPAR队列的PsA患者以及莱顿早期关节炎门诊(EAC)的RA和PsA患者,采用倾向性评分匹配RA与PsA患者后计算逆概率权重(IPW),并用IPW加权线性回归模型比较患者报告结局差异。
  • 共纳入tREACH的391例RA患者、DEPAR的416例PsA患者、EAC的702例RA患者和99例PsA患者。

主要发现

  • 诊断时PsA-DEPAR患者SF-36心理健康评分较RA-tREACH患者差5.04单位(95%CI 2.21至7.87)。
  • 治疗1年后PsA-DEPAR患者SF-36心理健康评分仍较RA-tREACH患者差3.88单位(95%CI 1.90至5.86)。
  • 治疗1年后PsA-EAC患者活动受限较RA-EAC患者更重(-0.30,95%CI -0.50至-0.10)。
  • 其他患者报告结局领域(疼痛、疲劳、总体健康等)在RA与PsA间无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Rheumatoid arthritis (RA) and psoriatic arthritis (PsA) are currently treated similarly. However, it is unclear which patient-reported outcome (PRO) domains need specific attention in the management of RA and PsA. Therefore, we aimed to determine the difference in disease impact between matched RA and PsA patients at diagnosis and after 1 year in two different regions. METHODS: RA patients from the treatment in the Rotterdam Early Arthritis CoHort trial (tREACH), PsA patients from the Dutch southwest Early PsA cohoRt (DEPAR) and RA and PsA patients from the Leiden Early Arthritis Clinic (EAC) were included. The difference in disease impact between RA and PsA was measured with the following PROs: pain (Visual Analogue Scale (VAS), 0-100), fatigue (VAS), activity limitation (Health Assessment Questionnaire-Disability Index) and health impact (general health (VAS) and 36-item Short-Form Health Survey (SF-36)). Propensity scores were used to match RA and PsA patients, after which inverse probability weights (IPWs) were calculated. IPW-weighted linear regression models were used to measure PRO differences. RESULTS: 391 RA patients from tREACH, 416 PsA patients from DEPAR, 702 RA and 99 PsA patients from the EAC were included. At diagnosis, PsA-DEPAR patients scored 5.04 units worse (95% CI 2.21 to 7.87) on SF-36 mental health compared with RA-tREACH patients. This difference still existed after 1 year of treatment (3.88 (95% CI 1.90 to 5.86)). PsA-EAC patients had more activity limitations after 1 year of treatment compared with RA-EAC patients (-0.30 (95% CI -0.50 to -0.10)). No significant differences were present in the other PRO domains. CONCLUSION: The disease impact of early RA patients is similar to matched early PsA patients on most PRO domains, except for mental health and functional limitations, which were worse in PsA after 1 year of treatment.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Snoeck Henkemans SVJ, van den Biggelaar AF, van Mulligen E, et al. Rheumatoid arthritis and psoriatic arthritis: is the disease impact different? A large matching study at diagnosis and after 1 year of treatment. RMD Open. 2025. PMID: 40081914. doi:10.1136/rmdopen-2024-005143

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。